50
Participants
Start Date
May 31, 2006
Primary Completion Date
February 29, 2008
Study Completion Date
May 31, 2008
Motexafin Gadolinium
"On Day 1 of each 3 week cycle for up to 12 cycles:~MGd 10 mg/kg infused over approximately 30 to 60 minutes, followed ≥ 30 minutes later by Docetaxel 75 mg/m2 administered IV over approximately 1 hour."
Wilshire Oncology Medical Group, La Verne
University of Rochester, Rochester
Tri-County Hematology & Oncology Associates, Canton
University of Cincinnati, Cincinnati
The Cleveland Clinic Foundation, Cleveland
Pennsylvania Oncology Hematology Associates, Philadelphia
Cancer Specialists of Tidewater, Chesapeake
Cancer Centre of Southeastern Ontario, Kingston
Hospital Charles Lemoyne, Greenfield Park
Jewish General Hospital, Montreal
Chelyabinsk Regional Oncology Dispensary, Chelyabinsk
Blokhin Cancer Research Center (Dept. of Chemotherapy), Moscow
Blokhin Cancer Research Center (Dept. of Clinical Pharmacology and Chemotherapy), Moscow
Central Clinical Hospital, Moscow
Moscow Oncology Hospital #62, Moscow
St. Petersburg City Oncology Center, Saint Petersburg
Samara Regional Oncology Center, Samara
Regional Oncology Dispensary, Yaroslavl
Clinic for Pulmonary Diseases, Military Medical Academy, Belgrade
Clinic for Pulmonary Diseases, Belgrade
Institute for Oncology and Radiology of Serbia, Belgrade
Institute for Pulmonary Diseases of Vojvodina, Kamenitz
Lead Sponsor
Pharmacyclics LLC.
INDUSTRY